Manja Brose

Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials

Leonardo M. Fabbri, Peter M.A. Calverley, José Luís Izquierdo Alonso et al. · The Lancet · 2009 · 604 citations · Full text

Longacting Bronchodilators, Advanced Lung Disease, Clinical Trials +4

Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents

Shibadas Biswal, Humberto Reynales, Xavier Sáez‐Llorens et al. · New England Journal of Medicine · 2019 · 357 citations · Full text

Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial

Fernando J. Martínez, Peter M.A. Calverley, Udo-Michael Goehring et al. · The Lancet · 2015 · 355 citations · Full text

Advanced Lung Disease, Pulmonary Medicine, Pharmacotherapy +3

Efficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled, phase 3 trial

Shibadas Biswal, Charissa Borja-Tabora, Luis Martinez Vargas et al. · The Lancet · 2020 · 237 citations

Vaccination, Vaccine Safety, Pediatrics +5

Roflumilast with long-acting β₂-agonists for COPD: influence of exacerbation history

Eric Bateman, Klaus F. Rabe, Peter M.A. Calverley et al. · European Respiratory Journal · 2011 · 119 citations · Full text